Additionally, during ICI treatment, F. nucleatum was found to increase the accumulation of IFN-γ+CD8+ T cells in CRC patients, thereby enhancing the cancer's sensitivity to anti-PD-L1 therapies [113]. Here, CD8A is linked to cancer.